Shengyu Zhou
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Sintilimab in Combination With Nab-paclitaxel in Patients With HNSCC (Head and Neck Squamous Cell Carcinoma ) (NCT03975270) | Shengyu Zhou | 2019-07-20 |
Track Shengyu Zhou automatically
Every clearance here is in the API, with alerts when new ones post.